Your browser doesn't support javascript.
loading
Neoadjuvant chemotherapy with sequential anthracycline-docetaxel with gemcitabine for large operable or locally advanced breast cancer: ANZ 0502 (NeoGem).
McCarthy, N; Boyle, F; Zdenkowski, N; Bull, J; Leong, E; Simpson, A; Kannourakis, G; Francis, P A; Chirgwin, J; Abdi, E; Gebski, V; Veillard, A S; Zannino, D; Wilcken, N; Reaby, L; Lindsay, D F; Badger, H D; Forbes, J F.
Afiliação
  • McCarthy N; Cancer Care Services, Royal Brisbane and Women's Hospital, Butterfield St, Herston, Brisbane, QLD 4029, Australia; University of Queensland, Brisbane, QLD, Australia. Electronic address: NMcCarthy@iconcancercare.com.au.
  • Boyle F; The Mater Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NSW, Australia.
  • Zdenkowski N; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia.
  • Bull J; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • Leong E; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • Simpson A; Wellington Cancer Centre, Wellington Hospital, Wellington, New Zealand.
  • Kannourakis G; Ballarat Oncology and Haematology Service, Ballarat, VIC, Australia.
  • Francis PA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Department of Medicine, St. Vincent's Hospital, University of Melbourne, VIC, Australia.
  • Chirgwin J; University of Newcastle, Newcastle, NSW, Australia; Box Hill Hospital, Box Hill, VIC, Australia; Maroondah Breast Clinic, Maroondah Hospital, Ringwood East, VIC, Australia; Monash University, VIC, Australia.
  • Abdi E; Tweed Hospital, Tweed Heads, NSW, Australia; Griffith University- Gold Coast, Southport, QLD, Australia.
  • Gebski V; National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia.
  • Veillard AS; National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia.
  • Zannino D; National Health and Medical Research Council Clinical Trials Centre, Sydney, NSW, Australia.
  • Wilcken N; Westmead Cancer Care Centre, Westmead Hospital, University of Sydney, NSW, Australia.
  • Reaby L; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • Lindsay DF; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • Badger HD; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia.
  • Forbes JF; Australia and New Zealand Breast Cancer Trials Group, Newcastle, NSW, Australia; University of Newcastle, Newcastle, NSW, Australia; Department of Surgical Oncology, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Breast ; 23(2): 142-51, 2014 Apr.
Article em En | MEDLINE | ID: mdl-24393617
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Epirubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Antraciclinas / Terapia Neoadjuvante / Ciclofosfamida / Taxoides / Desoxicitidina / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Epirubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Antraciclinas / Terapia Neoadjuvante / Ciclofosfamida / Taxoides / Desoxicitidina / Anticorpos Monoclonais Humanizados Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article